WASF2 and neoplasm: This is not surprising, having in mind that WAVE2, for example, can act as a tumor suppressor in benign tumors (stabilizing cell-cell adhesion) and, at the same time, as a driver of epithelial-mesenchymal transition in migrating cancer cells (inducing actin meshwork formation at the cellular leading edge) [58].